BioMS Medical Corp. Company Profile

09:29 EDT 18th March 2018 | BioPortfolio

BioMS Medical has obtained an exclusive worldwide license to a proprietary technology developed at the MS Patient Care and Research Clinic at the University of Alberta for the treatment of MS. The technology, MBP8298, is based on over 26 years of research and is a synthetic myelin basic protein peptide comprised of 17 amino acids which is intravenously injected into MS patients as a therapeutic treatment. BioMS Medical is currently conducting a pivotal Phase II/III human clinical trial of MBP8298 in patients with Secondary Progressive MS. Patient enrollment has began in Canada and Europe. The Company’s second technology, HYC750, involves a method for mobilizing hematopoetic cells in humans. BioMS has obtained an exclusive worldwide license to HYC750 from the University of Alberta. HYC750 is based on hyaluronic acid, a naturally occurring and vital component in the connective tissue of humans. Hyaluronic acid is currently used, in various forms, in a large number of commercially available products for applications such as ophthalmologic surgery, rheumatoid arthritis treatment, joint mobilization, wound healing and as a carrier matrix for cells and drugs. In those applications, hyaluronic acid has been shown to be very safe. HYC750 has a number of potential uses, however, the current focus of the Company is on its use as a treatment for the side effects of chemotherapy. BioMS has also entered into an agreement with the University of Alberta, Dr. Leonard I. Wiebe, Dr. James Diakur and BioCyDex Inc. ("BioCyDex"). BioCyDex has exclusive worldwide licenses from the University of Alberta for two technologies. One technology relates to the delivery of anti-viral and chemotherapy drugs into cells for the purpose of improving the effectiveness of those drugs. The other technology relates to the imaging of genes that have been delivered into cells as part of gene therapy treatment. Both technologies are at an early stage of development. BioMS Medical is a publicly traded company on the Toronto Stock Exchange (TSX: MS).


6030-88 Street
T6E 6G4


Phone: 780-413-7152
Fax: 780-408-3040

News Articles [228 Associated News Articles listed on BioPortfolio]

Helix BioPharma Corp. Announces Management Change

RICHMOND HILL, ONTARIO -- (Marketwired) -- 12/01/17 -- Helix BioPharma Corp. (TSX: HBP) (FRANKFURT: HBP), an immuno-oncology company developing drug candidates for the prevention and treatment of ca...

GTX Corp Third Quarter 2017 Summary Results

Los Angeles, CA, Nov. 20, 2017 (GLOBE NEWSWIRE) -- GTX Corp. (OTCQB: GTXO), an IoT platform and provider of personal location GPS wearable technology and wandering assistive technology, announces...

Emblem Corp. Provides Business Update for 2018

TORONTO, Dec. 04, 2017 (GLOBE NEWSWIRE) -- Emblem Corp. (“Emblem” or the “Company”) (TSXV:EMC), a vertically integrated cannabis company focused on research, development, production and d...

Scythian Biosciences Corp. Completes Sale of Go Green 

TORONTO, Nov. 30, 2017 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSX-V:SCYB) (Frankfurt:9SB) (OTC Pink:SCCYF) is pleased to announce that it has entered in...

GTX Corp and Veristride Presenting Biometric Insoles at CES 2018

LOS ANGELES, Jan. 04, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO), an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive technology business...

GTX Corp Comments on CES 2018, Super Bowl LII and the GPS SmartSoles on the Kardashians

LOS ANGELES, Jan. 17, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCBB:GTXO), an Internet of Things (IoT) solutions provider in the personal location, wearable and wandering assistive technology busines...

Scythian Biosciences Corp. Announces Upgrade to the OTCQB Marketplace

TORONTO, Jan. 10, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSX-V:SCYB) (Frankfurt:9SB) (OTCQB:SCCYF) is pleased to announce that it has been upgraded...

Scythian Biosciences Corp. Announces Proposed Up To 8 for 1 Stock Split

TORONTO, Jan. 04, 2018 (GLOBE NEWSWIRE) -- Scythian Biosciences Corp. (the "Company" or “Scythian”) (TSX-V:SCYB) (Frankfurt:9SB) (OTC Pink:SCCYF) announces that its Board of Directors has app...

PubMed Articles [1725 Associated PubMed Articles listed on BioPortfolio]

The MD-MEd Joint-Degree Program at Vanderbilt University: Training Future Expert Medical Educators.

Some medical students are drawn to medical education as an area of academic specialization. However, few options exist for medical students who wish to build a scholarly foundation for future careers ...

Medical specialty preferences in early medical school training in Canada.

To understand what medical students consider when choosing their specialty, prior to significant clinical exposure to develop strategies to provide adequate career counseling.

Physicians-in-training are not prepared to prescribe medical marijuana.

While medical marijuana use is legal in more than half of U.S. states, evidence is limited about the preparation of physicians-in-training to prescribe medical marijuana. We asked whether current medi...

Strategies for enhancing medical student resilience: student and faculty member perspectives.

To improve programs aimed to enhance medical student resiliency, we examined both medical student and faculty advisor perspectives on resiliency-building in an Asian medical school.

Married to Medical School? How to Maintain Relationships as a Medical Student.

Clinical Trials [1515 Associated Clinical Trials listed on BioPortfolio]

Feasibility of a Minimally Invasive Thoracoscopic Ultrasound for Localization of Pulmonary Nodules

The ex-vivo lung will be evaluated by XLTF-UC180 for localization of the tumor. The ultrasound probe will be put on the lung surface in several different directions to obtain the cross sec...

Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation

PCI (optimal catheter-based coronary revascularization) + intensive medical therapy is superior to intensive medical therapy alone using the combined endpoint of all-cause mortality or non...

Chart Review Study of Medical Abortion

The primary objective of this study is to document the rates of success and serious complications among women having outpatient medical abortions with 200 mg mifepristone + 800 buccal miso...

The Influence of Medical Clowns on the Performance of Pulmonary Function Tests Among Preschooler Children

Medical clowns are known to assist in relaxing children and allowing better cooperation during performance of medical procedures. The ability of medical clowns to improve the motivation o...

Does Follow-up With Serum Beta Human Chorionic Gonadotropin (BhCG) Simplify Medical Abortion?

The purpose of this study is to evaluate if BhCG testing to determine the completion of medical abortion simplifies the medical abortion protocol. Investigators hypothesize that women rand...

Companies [1203 Associated Companies listed on BioPortfolio]

BioMS Medical Corp.

BioMS Medical has obtained an exclusive worldwide license to a proprietary technology developed at the MS Patient Care and Research Clinic at the University of Alberta for the treatment of MS. The tec...

Hitachi Medical Systems America, Inc.

Hitachi Medical Systems America Inc. (HMSA) markets advanced diagnostic medical imaging systems of Hitachi Medical Corp., Tokyo, Japan. The company has more than 1,500 MRI systems...





Precision Engineered Products LLC

More Information about "BioMS Medical Corp." on BioPortfolio

We have published hundreds of BioMS Medical Corp. news stories on BioPortfolio along with dozens of BioMS Medical Corp. Clinical Trials and PubMed Articles about BioMS Medical Corp. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioMS Medical Corp. Companies in our database. You can also find out about relevant BioMS Medical Corp. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Corporate Database Quicklinks

Searches Linking to this Company Record